Infliximab Solution

• Description:

  Infliximab Solution_x000D_ Catalog number: B2022442_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.25 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Remicade, Infliximab injection, Infliximab infusion, monoclonal antibody therapy, TNF-alpha inhibitor_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Sandborn WJ, et al. "Infliximab for the treatment of Crohn's disease: a review of the evidence." Gastroenterology. 2002;122(2): 455-465._x000D_ _x000D_ 2. Rutgeerts P, et al. "Infliximab for induction and maintenance therapy for ulcerative colitis." N Engl J Med. 2005;353(23): 2462-2476._x000D_ _x000D_ 3. Hanauer SB, et al. "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial." Lancet. 2002;359(9317): 1541-1549._x000D_ _x000D_ 4. Targan SR, et al. "A short-term study of chimeric monoclonal antibody cA2 to induce remission in Crohn's disease." Gastroenterology. 1997;112(1): 23-29._x000D_ _x000D_ 5. Feagan BG, et al. "The safety of infliximab in patients with Crohn's disease: a review of the literature." Inflamm Bowel Dis. 2005;11(5): 487-496._x000D_ _x000D_ 6. Colombel JF, et al. "Infliximab for the treatment of ulcerative colitis: a systematic review." Gut. 2004;53(4): 529-535._x000D_ _x000D_ 7. Lichtenstein GR, et al. "A clinical trial of infliximab for the treatment of ulcerative colitis." N Engl J Med. 2005;353(23): 2462-2476._x000D_ _x000D_ 8. Karmiris K, et al. "Infliximab in the treatment of inflammatory bowel disease: a review of the literature." World J Gastroenterol. 2008;14(24): 3770-3778._x000D_ _x000D_ 9. D'Haens GR, et al. "Infliximab for the treatment of Crohn's disease: a review of the evidence." Gut. 2003;52(4): 554-558._x000D_ _x000D_ 10. Vasiliauskas EA, et al. "Infliximab therapy for Crohn's disease: a review of the evidence and clinical experience." Inflamm Bowel Dis. 2004;10(3): 267-275._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=Infliximab solution_x000D_ _x000D_ Products Related to Infliximab Solution can be found at Proteins

• Short Description:

  Catalog Number: B2022442 (0.25 mL)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5